Portuguese Tennis player Silva Receives One-Month Suspension Following Trimรฉtazidine Positive Test
September โ25, 2025 – Fredericoโ Ferreira Silva,โข a 30-year-old Portuguese โฃtennis player, has accepted a one-month suspension from the International Tennis Integrity agency โฃ(ITIA) after testing positive for the prohibited substance trimรฉtazidine (TMZ) during a competitionโข in February 2025. The ITIA confirmedโฃ the violation but resolute the positive test resulted from contamination โขof a regulated prescription medication andโค was not intentional.
The ITIA investigation, supported by laboratory analysis from lama confirming the presence of TMZ in Silva’s medication, a verification by an self-reliantโ expert from the ITIA (l’itia), and documentation from the dispensing pharmacy, led to the lifting of a provisional suspension.
According to the ITIA,โ Silva’s level of fault was deemed “very low” due to theโข contaminated product – DAFLON 1000 mg – being aโข legally prescribed drug issued by โฃa sports medicine specialist and purchased through his national tennis federation following medical consultation.
Having already served aโค period of ineligibility exceeding the standard duration for a provisional suspension โduring the investigation, Silva is now eligible to resume play.
Trimรฉtazidine is a metabolic agent prohibited under the Worldโ Anti-Doping โcode.While frequently enough โขprescribed for angina, its use in sports is banned due to potential performance-enhancingโ effects. This case highlights the complexitiesโข of anti-doping regulations and the potential for โinadvertent violations through contaminatedโฃ supplements or medications.
(Note: โThe Twitter embedโฃ code was omitted as โit’s not necessary for the rewritten article and can cause rendering issues in some contexts.)